Ezetimibe 10mg Tablets
*Company:
Gerard LaboratoriesStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 29 April 2024
File name
ie-combined-nl2923-v024-clean_29Apr2024.pdf
Reasons for updating
- Change to section 6 - what the product looks like and pack contents
Updated on 11 May 2023
File name
ie-pl-nl2923-v021g-v022-clean.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
- Change to name of medicinal product
Updated on 10 June 2022
File name
ie-pl-nl2923-v019-clean.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to name of medicinal product
Updated on 09 March 2022
File name
ie-pl-nl2923-v017-clean.pdf
Reasons for updating
- Change to name of medicinal product
Updated on 05 November 2021
File name
ie-pl-nl2923-p001-clean.pdf
Reasons for updating
- Change to section 3 - use in children/adolescents
- Change to section 6 - date of revision
Updated on 28 October 2021
File name
ie-pl-nl2923-v015g-clean.pdf
Reasons for updating
- Change to section 6 - what the product looks like and pack contents
- Change to section 6 - date of revision
Updated on 28 October 2021
File name
ie-spc-nl2923-v015g-clean.pdf
Reasons for updating
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 26 January 2021
File name
ie-spc-nl2923-v013-v014-clean.pdf
Reasons for updating
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 26 January 2021
File name
ie-pil-nl2923-v013-v014-clean.pdf
Reasons for updating
- Change to section 6 - what the product looks like and pack contents
- Change to section 6 - date of revision
Updated on 11 January 2021
File name
ie-SPC-nl2923-v012-clean.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 11 January 2021
File name
ie-PIL-nl2923-v012-clean.pdf
Reasons for updating
- Change to section 2 - excipient warnings
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
Updated on 31 January 2019
File name
ezetimibe pil.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - marketing authorisation number
- Change to section 6 - date of revision
Updated on 30 January 2019
File name
ezetimibe spc.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 05 June 2018
File name
ie-combined-nl2923-clean-v006.docx
Reasons for updating
- New SPC for medicines.ie
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 16 May 2018
File name
ie-combined-nl2923-clean-v006.docx
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 26 April 2018
File name
PIL Ezetimibe.pdf
Reasons for updating
- New PIL for new product